content

NICE Has Granted Its Endorsement To Beovu From Novartis

Following NICE's recommendation of a novel therapy alternative for diabetic macular oedema (DMO), thousands of patients could receive transformative care. In the final form...

Solving Controlled Release Drug Delivery Challenges Using Extrusion-Spheronization

Overcome your controlled release drug delivery challenges through extrusion-spheronization Combining best-in-class drug technology with a proven drug strategy Extrusion-spheronization (E-S) is a robust technique that synchronizes...

Lilly, AZ, AbbVie, J&J May Be Hit By Medicare Pricing Bill

Could the Senateย adopt a "watershed" bill allowing drug price discussions after years of government inaction regarding medication prices in the U.S.? Analysts are busy...

Cyclerion Provides Information On Schizophrenia Treatment

Positive top-line statistics from Cyclerion Therapeutics' clinical investigation of CY6463 for the treatment of cognitive impairment associated with schizophrenia have been released. It concerns...

Tallac Reveal They Have Served Their First TAC-001 Patient

In a phase 1/2 clinical trial for patients with locally advanced or metastatic solid tumours, Tallac Therapeutics has reported that the first patient has...

September May Bring Updated COVID-19 Booster Shots To Market

According to the US Department of Health and Human Services, booster shots from Moderna and Pfizer that have been upgraded to target Omicron coronavirus...

Zoryve Cream By Arcutis Receives FDA Approval For Psoriasis

Pfizer previously held out hope that Eucrisa would become the trendiest topical treatment for inflammatory skin conditions. However, the ointment never took off because...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read